Read theCell paper, published September 10, 2024, titled Safe and Effective Delivery of DNA and RNA Using Proteolipid Vehicles. DOI: 10.1016/j.cell.2024.07.023 Also available on ScienceDirect Citation: Brown, D.W., Wee, P., Bhandari, P., Bukhari, A., Grin, L., Vega, H., Hejazi, M., Sosnowski, D., Ablack, J., Clancy, E.K., et
Read more →Press Release Entos Pharmaceuticals Announces First Participant Dosed in Clinical Trial for COVID-19 Vaccine Booster First participant dosed in the Covigenix VAX-002 Phase 1/2 Study to Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA Booster Vaccine Against SARS-CoV-2 August 06, 2024 08:00 AM Eastern Daylight Time
Read more →Press Release Aegis Life receives a program-related investment of $4.45M from the Bill & Melinda Gates Foundation This investment supports the continuation of the ongoing research collaboration between Aegis Life and Entos Pharmaceuticals Aegis Life is developing novel DNA-based encoded antibody therapeutics against HIV and malaria using
Read more →